The HERA W10 Elite ultrasound platform provides enhanced visualization features and artificial intelligence (AI)-aided measurement capabilities.
Could the HERA W10 Elite reinvent ultrasound imaging in obstetrics and gynecology care?
The newly launched ultrasound system offers 2D and 3D visualization of microcirculatory and slow blood with the Advanced MV-Flow™ feature and a large organic light-emitting diode (OLED) display that provides improved characterization of diverse ultrasound images, according to Samsung, the manufacturer of the HERA W10 Elite system.
Samsung said the HERA W10 Elite also has HeartAssist™, an artificial intelligence (AI)-enhanced feature that provides automated measurement views to facilitate diagnosis of the fetal heart.
(Editor’s note: For related content, see “Adjunctive AI Software for Cardiac Ultrasound Gets FDA Nod” and “Emerging Trends in AI, Ultrasound and OB/GYN Care.”)
Other planned features, pending 510(k) clearance from the Food and Drug Administration (FDA), include a new EV2-12 transducer that allows imaging of the fetal heart and brain starting at eight weeks and Biometry Assist™, which allows one-click measurement of fetal growth parameters.
“Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to obstetrics and gynecology with sophisticated image processing and an ergonomic-friendly design,” noted Tracy Bury, Women’s Health Ultrasound Business Leader with Boston Imaging, the United States headquarters for Samsung’s digital radiography and ultrasound business.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.